(IEFA) iShares Core MSCI EAFE - Ratings and Ratios
Stocks, Europe, Asia-Pacific, Market-Cap
Dividends
| Dividend Yield | 2.89% |
| Yield on Cost 5y | 4.43% |
| Yield CAGR 5y | 16.78% |
| Payout Consistency | 89.8% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 12.7% |
| Value at Risk 5%th | 21.3% |
| Relative Tail Risk | 1.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.17 |
| Alpha | 13.54 |
| CAGR/Max DD | 1.14 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.359 |
| Beta | 0.667 |
| Beta Downside | 0.646 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.76% |
| Mean DD | 2.66% |
| Median DD | 1.77% |
Description: IEFA iShares Core MSCI EAFE December 02, 2025
The iShares Core MSCI EAFE ETF (BATS: IEFA) seeks to track the MSCI EAFE Index by investing at least 80 % of its assets in the index’s component securities or in assets with substantially identical economic characteristics. The index covers large-, mid- and small-cap equities across Europe, Australasia and the Far East, providing broad exposure to developed-market non-U.S. stocks.
Key metrics (as of Q3 2024) include an expense ratio of 0.07 %, a weighted-average dividend yield near 2.8 %, and a currency-hedged version (IEFA H) that reduces exposure to EUR, GBP, JPY and AUD fluctuations. The fund’s top sector allocations are Financials (~18 %), Consumer Staples (~15 %), and Health Care (~14 %), reflecting the relative strength of these industries in the underlying markets.
Economic drivers such as the Eurozone’s monetary-policy stance, Australia’s commodity export demand, and Japan’s corporate governance reforms can materially affect IEFA’s performance. Monitoring these macro factors alongside the fund’s valuation multiples (e.g., forward P/E ≈ 15×) can help gauge upside potential.
For a deeper dive into IEFA’s valuation metrics, you may find ValueRay’s analytical tools useful.
What is the price of IEFA shares?
Over the past week, the price has changed by +0.97%, over one month by +1.28%, over three months by +4.04% and over the past year by +25.77%.
Is IEFA a buy, sell or hold?
What are the forecasts/targets for the IEFA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 105 | 16.7% |
IEFA Fundamental Data Overview December 03, 2025
Beta = 1.07
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 160.03b USD (160.03b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 160.03b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 160.03b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.47% (E(160.03b)/V(160.03b) * Re(8.47%) + (debt-free company))
Discount Rate = 8.47% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IEFA ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle